Abstract
Many toxic compounds exert their harmful effects by activating of certain receptors, which in turn leads to dysregulation of transcription. Some of these receptors are so called xenosensors. They are activated by external chemicals and evoke a cascade of events that lead to the elimination of the chemical from the system. Other receptors that are modulated by toxic substances are hormone receptors, particularly the ones of the nuclear receptor family. Some environmental chemicals resemble endogenous hormones and can falsely activate these receptors, leading to undesired activity in the cell. Furthermore, excessive activation of the xenosensors can lead to disturbances of the integrity of the system as well. In this chapter, the concepts of receptor-mediated toxicity and hormone disruption are introduced. We start by describing environmental chemicals that can bind to xenosensors and nuclear hormone receptors. We then describe the receptors most commonly targeted by environmental chemicals. Finally, the mechanisms by which receptor-mediated events can disrupt the system are depicted.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lemaire G, Mnif W, Mauvais P, Balaguer P, Rahmani R (2006) Activation of a-and b-estrogen receptors by persistent pesticides in reporter cell lines. Life Sci 79: 1160–1169
Kavlock R, Cummings A (2005) Mode of action: Inhibition of androgen receptor function-Vinclozolin-induced malformations in reproductive development. Crit Rev Toxicol 35: 721–726
Molina-Molina JM, Hillenweck A, Jouanin I, Zalko D, Cravedi JP, Fernandez MF, Pillon A, Nicolas JC, Olea N, Balaguer P (2006) Steroid receptor profiling of vinclozolin and its primary metabolites. Toxicol Appl Pharmacol 216: 44–54
Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor b. Endocrinology 139: 4252–4263
Bonefeld-Jorgensen EC, Long M, Hofmeister MV, Vinggaard AM (2007) Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: New data and a brief review. Environ Health Perspect 115 Suppl 1: 69–76
Kitamura S, Suzuki T, Sanoh S, Kohta R, Jinno N, Sugihara K, Yoshihara S, Fujimoto N, Watanabe H, Ohta S (2005) Comparative study of the endocrine-disrupting activity of bisphenol A and 19 related compounds. Toxicol Sci 84: 249–259
Fini JB, Le Mevel S, Turque N, Palmier K, Zalko D, Cravedi JP, Demeneix BA (2007) An in vivo multiwell-based fluorescent screen for monitoring vertebrate thyroid hormone disruption. Environ Sci Technol 41: 5908–5914
Belpomme D, Irigaray P, Hardell L, Clapp R, Montagnier L, Epstein S, Sasco AJ (2007) The multitude and diversity of environmental carcinogens. Environ Res 105: 414–429
Costa LG, Giordano G, Guizzetti M, Vitalone A (2008) Neurotoxicity of pesticides: A brief review. Front Biosci 13: 1240–1249
Repetto R, Baliga SS (1997) Pesticides and immunosuppression: The risks to public health. Health Policy Plan 12: 97–106
Arcaro KF, O’Keefe PW,Yang Y, Clayton W, Gierthy JF (1999) Antiestrogenicity of environmental polycyclic aromatic hydrocarbons in human breast cancer cells. Toxicology 133: 115–127
Swedenborg E, Ruegg J, Hillenweck A, Rehnmark S, Faulds MH, Zalko D, Pongratz I, Pettersson K (2008) 3-Methylcholanthrene displays dual effects on estrogen receptor (ER) a and ER b signaling in a cell-type specific fashion. Mol Pharmacol 73: 575–586
Bock KW, Kohle C (2006) Ah receptor: Dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochem Pharmacol 72: 393–404
IARC (1997) Working Group on the Evaluation of Carcinogenic Risks to Humans: Polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans. IARC Monogr Eval Carcinog Risks Hum 69: 1–631
Remillard RB, Bunce NJ (2002) Linking dioxins to diabetes: Epidemiology and biologic plausibility. Environ Health Perspect 110: 853–858
Warner M, Eskenazi B, Mocarelli P, Gerthoux PM, Samuels S, Needham L, Patterson D, Brambilla P (2002) Serum dioxin concentrations and breast cancer risk in the Seveso Women’s Health Study. Environ Health Perspect 110: 625–628
Wynne-Edwards KE (2001) Evolutionary biology of plant defenses against herbivory and their predictive implications for endocrine disruptor susceptibility in vertebrates. Environ Health Perspect 109: 443–448
Denison MS, Nagy SR (2003) Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43: 309–334
Amakura Y, Tsutsumi T, Sasaki K, Nakamura M, Yoshida T, Maitani T (2008) Influence of food polyphenols on aryl hydrocarbon receptor-signaling pathway estimated by in vitro bioassay. Phytochemistry; in press
Sanders TH, McMichael RW Jr, Hendrix KW (2000) Occurrence of resveratrol in edible peanuts. J Agric Food Chem 48: 1243–1246
Rimando AM, Kalt W, Magee JB, Dewey J, Ballington JR (2004) Resveratrol, pterostilbene, and piceatannol in vaccinium berries. J Agric Food Chem 52: 4713–4719
Gillner M, Bergman J, Cambillau C, Fernstrom B, Gustafsson JA (1985) Interactions of indoles with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Mol Pharmacol 28: 357–363
Ciolino HP, Daschner PJ, Yeh GC (1998) Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res 58: 5707–5712
Casper RF, Quesne M, Rogers IM, Shirota T, Jolivet A, Milgrom E, Savouret JF (1999) Resveratrol has antagonist activity on the aryl hydrocarbon receptor: Implications for prevention of dioxin toxicity. Mol Pharmacol 56: 784–790
Chen ZH, Hurh YJ, Na HK, Kim JH, Chun YJ, Kim DH, Kang KS, Cho MH, Surh YJ (2004) Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogenReceptors mediating toxicity and their involvement in endocrine disruption 319 mediated oxidative DNA damage in cultured human mammary epithelial cells. Carcinogenesis 25: 2005–2013
Bradbury RB, White DE (1954) Estrogens and related substances in plants. Vitam Horm 12: 207–233
Benassayag C, Perrot-Applanat M, Ferre F (2002) Phytoestrogens as modulators of steroid action in target cells. J Chromatogr B Analyt Technol Biomed Life Sci 777: 233–248
Penttinen P, Jaehrling J, Damdimopoulos AE, Inzunza J, Lemmen JG, van der Saag P, Pettersson K, Gauglitz G, Makela S, Pongratz I (2007) Diet-derived polyphenol metabolite enterolactone is a tissue-specific estrogen receptor activator. Endocrinology 148: 4875–4886
Mueller SO, Simon S, Chae K, Metzler M, Korach KS (2004) Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor a (ERa) and ERb in human cells. Toxicol Sci 80: 14–25
Helguero LA, Faulds MH, Gustafsson JA, Haldosen LA (2005) Estrogen receptors a (ERa) and b (ERb) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene 24: 6605–6616
Moutsatsou P (2007) The spectrum of phytoestrogens in nature: Our knowledge is expanding. Hormones (Athens) 6: 173–193
Adlercreutz H (2002) Phyto-oestrogens and cancer. Lancet Oncol 3: 364–373
Nakata K, Tanaka Y, Nakano T, Adachi T, Tanaka H, Kaminuma T, Ishikawa T (2006) Nuclear receptor-mediated transcriptional regulation in phase I, II, and III xenobiotic metabolizing systems. Drug Metab Pharmacokinet 21: 437–457
Kliewer SA, Willson TM (2002) Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor. J Lipid Res 43: 359–364
Pascussi JM, Gerbal-Chaloin S, Drocourt L, Assenat E, Larrey D, Pichard-Garcia L, Vilarem MJ, Maurel P (2004) Cross-talk between xenobiotic detoxication and other signalling pathways: Clinical and toxicological consequences. Xenobiotica 34: 633–664
Gu YZ, Hogenesch JB, Bradfield CA (2000) The PAS superfamily: Sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 40: 519–561
Keith B, Adelman DM, Simon MC (2001) Targeted mutation of the murine arylhydrocarbon receptor nuclear translocator 2 (Arnt2) gene reveals partial redundancy with Arnt. Proc Natl Acad Sci USA 98: 6692–6697
Takahata S, Sogawa K, Kobayashi A, Ema M, Mimura J, Ozaki N, Fujii-Kuriyama Y (1998) Transcriptionally active heterodimer formation of an Arnt-like PAS protein, Arnt3, with HIF-1a, HLF, and clock. Biochem Biophys Res Commun 248: 789–794
Rowlands JC, Gustafsson JA (1997) Aryl hydrocarbon receptor-mediated signal transduction. Crit Rev Toxicol 27: 109–134
Wilson CL, Safe S (1998) Mechanisms of ligand-induced aryl hydrocarbon receptor-mediated biochemical and toxic responses. Toxicol Pathol 26: 657–671
Schmidt JV, Bradfield CA (1996) Ah receptor signaling pathways. Annu Rev Cell Dev Biol 12: 55–89
Poland A, Knutson JC (1982) 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: Examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 22: 517–554
Petrulis JR, Perdew GH (2002) The role of chaperone proteins in the aryl hydrocarbon receptor core complex. Chem Biol Interact 141: 25–40
Hankinson O (2005) Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor. Arch Biochem Biophys 433: 379–386
Matthews J, Wihlen B, Thomsen J, Gustafsson JA (2005) Aryl hydrocarbon receptor-mediated transcription: Ligand-dependent recruitment of estrogen receptor a to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters. Mol Cell Biol 25: 5317–5328
Kollara A, Brown TJ (2006) Functional interaction of nuclear receptor coactivator 4 with aryl hydrocarbon receptor. Biochem Biophys Res Commun 346: 526–534
Son DS, Roby KF, Rozman KK, Terranova PF (2002) Estradiol enhances and estriol inhibits the expression of CYP1A1 induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in a mouse ovarian cancer cell line. Toxicology 176: 229–243
Spink DC, Katz BH, Hussain MM, Pentecost BT, Cao Z, Spink BC (2003) Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells. Carcinogenesis 24: 1941–1950
Mimura J, Ema M, Sogawa K, Fujii-Kuriyama Y (1999) Identification of a novel mechanism of 320 J. Rüegg et al. regulation of Ah (dioxin) receptor function. Genes Dev 13: 20–25
Evans BR, Karchner SI, Allan LL, Pollenz RS, Tanguay RL, Jenny MJ, Sherr DH, Hahn ME (2008) Repression of aryl hydrocarbon receptor (AHR) signaling by AHR repressor: Role of DNA binding and competition for AHR nuclear translocator. Mol Pharmacol 73: 387–398
Dunlap JC, Loros JJ, Liu Y, Crosthwaite SK (1999) Eukaryotic circadian systems: Cycles in common. Genes Cells 4: 1–10
Klinge CM, Jernigan SC, Risinger KE, Lee JE, Tyulmenkov VV, Falkner KC, Prough RA (2001) Short heterodimer partner (SHP) orphan nuclear receptor inhibits the transcriptional activity of aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT). Arch Biochem Biophys 390: 64–70
Kumar MB, Tarpey RW, Perdew GH (1999) Differential recruitment of coactivator RIP140 by Ah and estrogen receptors. Absence of a role for LXXLL motifs. J Biol Chem 274: 22155–22164
Sadek CM, Jalaguier S, Feeney EP, Aitola M, Damdimopoulos AE, Pelto-Huikko M, Gustafsson JA (2000) Isolation and characterization of AINT: A novel ARNT interacting protein expressed during murine embryonic development. Mech Dev 97: 13–26
Puga A, Xia Y, Elferink C (2002) Role of the aryl hydrocarbon receptor in cell cycle regulation. Chem Biol Interact 141: 117–130
Weiss C, Faust D, Durk H, Kolluri SK, Pelzer A, Schneider S, Dietrich C, Oesch F, Göttlicher M (2005) TCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated p38-MAPKdependent pathway. Oncogene 24: 4975–4983
Oesch-Bartlomowicz B, Huelster A, Wiss O, Antoniou-Lipfert P, Dietrich C, Arand M, Weiss C, Bockamp E, Oesch F (2005) Aryl hydrocarbon receptor activation by cAMP versus dioxin: Divergent signaling pathways. Proc Natl Acad Sci USA 102: 9218–9223
Reen RK, Cadwallader A, Perdew GH (2002) The subdomains of the transactivation domain of the aryl hydrocarbon receptor (AhR) inhibit AhR and estrogen receptor transcriptional activity. Arch Biochem Biophys 408: 93–102
Kohle C, Bock KW (2007) Coordinate regulation of phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2. Biochem Pharmacol 73: 1853–1862
Nebert DW, Roe AL, Dieter MZ, Solis WA,Yang Y, Dalton TP (2000) Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem Pharmacol 59: 65–85
Lahvis GP, Bradfield CA (1998) Ahr null alleles: Distinctive or different? Biochem Pharmacol 56: 781–787
Fernandez-Salguero PM, Hilbert DM, Rudikoff S, Ward JM, Gonzalez FJ (1996) Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol 140: 173–179
Peters JM, Narotsky MG, Elizondo G, Fernandez-Salguero PM, Gonzalez FJ, Abbott BD (1999) Amelioration of TCDD-induced teratogenesis in aryl hydrocarbon receptor (AhR)-null mice. Toxicol Sci 47: 86–92
Lin TM, Ko K, Moore RW, Simanainen U, Oberley TD, Peterson RE (2002) Effects of aryl hydrocarbon receptor null mutation and in utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on prostate and seminal vesicle development in C57BL/6 mice. Toxicol Sci 68: 479–487
Andersson P, McGuire J, Rubio C, Gradin K, Whitelaw ML, Pettersson S, Hanberg A, Poellinger L (2002) A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors. Proc Natl Acad Sci U S A 99: 9990–9995
Seidel SD, Winters GM, Rogers WJ, Ziccardi MH, Li V, Keser B, Denison MS (2001) Activation of the Ah receptor signaling pathway by prostaglandins. J Biochem Mol Toxicol 15: 187–196
Rannug U, Rannug A, Sjoberg U, Li H,Westerholm R, Bergman J (1995) Structure elucidation of two tryptophan-derived, high affinity Ah receptor ligands. Chem Biol 2: 841–845
Adachi J, Mori Y, Matsui S, Takigami H, Fujino J, Kitagawa H, Miller CA 3rd, Kato T, Saeki K, Matsuda T (2001) Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J Biol Chem 276: 31475–31478
Mukai M, Tischkau SA (2007) Effects of tryptophan photoproducts in the circadian timing system: Searching for a physiological role for aryl hydrocarbon receptor. Toxicol Sci 95: 172–181
Gronemeyer H, Gustafsson JA, Laudet V (2004) Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov 3: 950–964
Picard D (2006) Chaperoning steroid hormone action. Trends Endocrinol Metab 17: 229–235
Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Strom A, Turner E, Warner M, Gustafsson JA (2007) Estrogen receptors: How do they signal and what are their targets. Physiol Rev 87: 905–931
Lee KC, Lee Kraus W (2001) Nuclear receptors, coactivators and chromatin: New approaches, new insights. Trends Endocrinol Metab 12: 191–197
Timsit YE, Negishi M (2007) CAR and PXR: The xenobiotic-sensing receptors. Steroids 72: 231–246
Tabb MM, Kholodovych V, Grun F, Zhou C, Welsh WJ, Blumberg B (2004) Highly chlorinated PCBs inhibit the human xenobiotic response mediated by the steroid and xenobiotic receptor (SXR). Environ Health Perspect 112: 163–169
Tzameli I, Moore DD (2001) Role reversal: New insights from new ligands for the xenobiotic receptor CAR. Trends Endocrinol Metab 12: 7–10
Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM et al (2000) Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 275: 15122–15127
Kobayashi K, Sueyoshi T, Inoue K, Moore R, Negishi M (2003) Cytoplasmic accumulation of the nuclear receptor CAR by a tetratricopeptide repeat protein in HepG2 cells. Mol Pharmacol 64: 1069–1075
Squires EJ, Sueyoshi T, Negishi M (2004) Cytoplasmic localization of pregnane X receptor and ligand-dependent nuclear translocation in mouse liver. J Biol Chem 279: 49307–49314
Wang K, Mendy AJ, Dai G, Luo HR, He L, Wan YJ (2006) Retinoids activate the RXR/SXRmediated pathway and induce the endogenous CYP3A4 activity in Huh7 human hepatoma cells. Toxicol Sci 92: 51–60
Ding X, Staudinger JL (2005) Induction of drug metabolism by forskolin: The role of the pregnane X receptor and the protein kinase a signal transduction pathway. J Pharmacol Exp Ther 312: 849–856
Baes M, Gulick T, Choi HS, Martinoli MG, Simha D, Moore DD (1994) A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol Cell Biol 14: 1544–1552
Maglich JM, Stoltz CM, Goodwin B, Hawkins-Brown D, Moore JT, Kliewer SA (2002) Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol 62: 638–646
Kretschmer XC, Baldwin WS (2005) CAR and PXR: Xenosensors of endocrine disrupters? Chem Biol Interact 155: 111–128
Handschin C, Meyer UA (2005) Regulatory network of lipid-sensing nuclear receptors: Roles for CAR, PXR, LXR, and FXR. Arch Biochem Biophys 433: 387–396
Jensen EV, Jacobson HJ (1962) Basic guides to the mechanism of estrogen action. Recent Prog Horm Res 18: 318–414
Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA (1996) Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93: 5925–5930
Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjold M, Gustafsson JA (1997) Human estrogen receptor b-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 82: 4258–4265
Flouriot G, Brand H, Denger S, Metivier R, Kos M, Reid G, Sonntag-Buck V, Gannon F (2000) Identification of a new isoform of the human estrogen receptor-a (hER-a) that is encoded by distinct transcripts and that is able to repress hER-a activation function 1. EMBO J 19: 4688–4700
Saunders PT, Millar MR, Williams K, Macpherson S, Harkiss D, Anderson RA, Orr B, Groome NP, Scobie G, Fraser HM (2000) Differential expression of estrogen receptor-a and-b and androgen receptor in the ovaries of marmosets and humans. Biol Reprod 63: 1098–1105
Gruber CJ, Gruber DM, Gruber IM,Wieser F, Huber JC (2004) Anatomy of the estrogen response element. Trends Endocrinol Metab 15: 73–78
Couse JF, Korach KS (1999) Estrogen receptor null mice: What have we learned and where will they lead us? Endocr Rev 20: 358–417
Hewitt SC, Harrell JC, Korach KS (2005) Lessons in estrogen biology from knockout and transgenic animals. Annu Rev Physiol 67: 285–308
Harris HA (2007) Estrogen receptor-b: Recent lessons from in vivo studies. Mol Endocrinol 21: 1–13
Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O (1993) Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse 322 J. Rüegg et al. estrogen receptor gene. Proc Natl Acad Sci USA 90: 11162–11166
Krege JH, Hodgin JB, Couse JF, Enmark E,Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA, Smithies O (1998) Generation and reproductive phenotypes of mice lacking estrogen receptor b. Proc Natl Acad Sci USA 95: 15677–15682
Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M (2000) Effect of single and compound knockouts of estrogen receptors a (ERa) and b (ERb) on mouse reproductive phenotypes. Development 127: 4277–4291
Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D, Hodgin J, Shaul PW, Thoren P, Smithies O, Gustafsson JA, Mendelsohn ME (2002) Abnormal vascular function and hypertension in mice deficient in estrogen receptor b. Science 295: 505–508
Imamov O, Morani A, Shim GJ, Omoto Y, Thulin-Andersson C,Warner M, Gustafsson JA (2004) Estrogen receptor b regulates epithelial cellular differentiation in the mouse ventral prostate. Proc Natl Acad Sci USA 101: 9375–9380
Wada-Hiraike O, Imamov O, Hiraike H, Hultenby K, Schwend T, Omoto Y, Warner M, Gustafsson JA (2006) Role of estrogen receptor b in colonic epithelium. Proc Natl Acad Sci USA 103: 2959–2964
Krezel W, Dupont S, Krust A, Chambon P, Chapman PF (2001) Increased anxiety and synaptic plasticity in estrogen receptor b-deficient mice. Proc Natl Acad Sci USA 98: 12278–12282
Imwalle DB, Gustafsson JA, Rissman EF (2005) Lack of functional estrogen receptor b influences anxiety behavior and serotonin content in female mice. Physiol Behav 84: 157–163
Liu MM, Albanese C, Anderson CM, Hilty K, Webb P, Uht RM, Price RH Jr, Pestell RG, Kushner PJ (2002) Opposing action of estrogen receptors a and b on cyclin D1 gene expression. J Biol Chem 277: 24353–24360
Matthews J, Gustafsson JA (2003) Estrogen signaling: A subtle balance between ER a and ER b. Mol Interv 3: 281–292
Wilson CM, McPhaul MJ (1994) A and B forms of the androgen receptor are present in human genital skin fibroblasts. Proc Natl Acad Sci USA 91: 1234–1238
Takeda H, Chodak G, Mutchnik S, Nakamoto T, Chang C (1990) Immunohistochemical localization of androgen receptors with mono-and polyclonal antibodies to androgen receptor. J Endocrinol 126: 17–25
Wilson CM, McPhaul MJ (1996) A and B forms of the androgen receptor are expressed in a variety of human tissues. Mol Cell Endocrinol 120: 51–57
Heinlein CA, Chang C (2002) The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol Endocrinol 16: 2181–2187
Yen PM (2001) Physiological and molecular basis of thyroid hormone action. Physiol Rev 81: 1097–1142
Chassande O, Fraichard A, Gauthier K, Flamant F, Legrand C, Savatier P, Laudet V, Samarut J (1997) Identification of transcripts initiated from an internal promoter in the c-erbA a locus that encode inhibitors of retinoic acid receptor-a and triiodothyronine receptor activities. Mol Endocrinol 11: 1278–1290
Plateroti M, Gauthier K, Domon-Dell C, Freund JN, Samarut J, Chassande O (2001) Functional interference between thyroid hormone receptor a (TRa) and natural truncated TRda isoforms in the control of intestine development. Mol Cell Biol 21: 4761–4772
Boas M, Feldt-Rasmussen U, Skakkebaek NE, Main KM (2006) Environmental chemicals and thyroid function. Eur J Endocrinol 154: 599–611
Bassett JH, Harvey CB, Williams GR (2003) Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol Cell Endocrinol 213: 1–11
Li X, Lonard DM, O’Malley BW (2004) A contemporary understanding of progesterone receptor function. Mech Ageing Dev 125: 669–678
Bentrem D, Fox JE, Pearce ST, Liu H, Pappas S, Kupfer D, Zapf JW, Jordan VC (2003) Distinct molecular conformations of the estrogen receptor a complex exploited by environmental estrogens. Cancer Res 63: 7490–7496
Nagel SC, Hagelbarger JL, McDonnell DP (2001) Development of an ER action indicator mouse for the study of estrogens, selective ER modulators (SERMs), and xenobiotics. Endocrinology 142: 4721–4728
Hall JM, McDonnell DP (2005) Coregulators in nuclear estrogen receptor action: From concept to therapeutic targeting. Mol Interv 5: 343–357
Hestermann EV, Brown M (2003) Agonist and chemopreventative ligands induce differential Receptors mediating toxicity and their involvement in endocrine disruption 323 transcriptional cofactor recruitment by aryl hydrocarbon receptor. Mol Cell Biol 23: 7920–7925
Safe S, Wormke M (2003) Inhibitory aryl hydrocarbon receptor-estrogen receptor a cross-talk and mechanisms of action. Chem Res Toxicol 16: 807–816
Safe S,Wormke M, Samudio I (2000) Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells. J Mammary Gland Biol Neoplasia 5: 295–306
Brunnberg S, Pettersson K, Rydin E, Matthews J, Hanberg A, Pongratz I (2003) The basic helixloop-helix-PAS protein ARNT functions as a potent coactivator of estrogen receptor-dependent transcription. Proc Natl Acad Sci USA 100: 6517–6522
Ruegg J, Swedenborg E, Wahlström D, Escande A, Balaguer P, Pettersson K, Pongratz I (2008) The transcription factor aryl hydrocarbon receptor nuclear translocator functions as an estrogen receptor b-selective co-activator, and its recruitment to alternative pathways mediates antiestrogenic effects of dioxin. Mol Endocrinol 22: 304–316
Min G, Kim H, Bae Y, Petz L, Kemper JK (2002) Inhibitory cross-talk between estrogen receptor (ER) and constitutively activated androstane receptor (CAR). CAR inhibits ER-mediated signaling pathway by squelching p160 coactivators. J Biol Chem 277: 34626–34633
Tsuchiya Y, Nakajima M, Yokoi T (2005) Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett 227: 115–124
Tsuchiya Y, Nakajima M, Kyo S, Kanaya T, Inoue M, Yokoi T (2004) Human CYP1B1 is regulated by estradiol via estrogen receptor. Cancer Res 64: 3119–3125
You L (2004) Steroid hormone biotransformation and xenobiotic induction of hepatic steroid metabolizing enzymes. Chem Biol Interact 147: 233–246
Porter W, Wang F, Duan R, Qin C, Castro-Rivera E, Kim K, Safe S (2001) Transcriptional activation of heat shock protein 27 gene expression by 17b-estradiol and modulation by antiestrogens and aryl hydrocarbon receptor agonists. J Mol Endocrinol 26: 31–42
Wang F, Samudio I, Safe S (2001) Transcriptional activation of cathepsin D gene expression by 17b-estradiol: Mechanism of aryl hydrocarbon receptor-mediated inhibition. Mol Cell Endocrinol 172: 91–103
Gillesby BE, Stanostefano M, Porter W, Safe S,Wu ZF, Zacharewski TR (1997) Identification of a motif within the 5’ regulatory region of pS2 which is responsible for AP-1 binding and TCDDmediated suppression. Biochemistry 36: 6080–6089
Hockings JK, Thorne PA, Kemp MQ, Morgan SS, Selmin O, Romagnolo DF (2006) The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen. Cancer Res 66: 2224–2232
Lin HK, Altuwaijri S, Lin WJ, Kan PY, Collins LL, Chang C (2002) Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells. J Biol Chem 277: 36570–36576
Deroo BJ, Rentsch C, Sampath S, Young J, DeFranco DB, Archer TK (2002) Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking. Mol Cell Biol 22: 4113–4123
Wijayaratne AL, McDonnell DP (2001) The human estrogen receptor-a is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. J Biol Chem 276: 35684–35692
Ohtake F, Baba A, Takada I, Okada M, Iwasaki K, Miki H, Takahashi S, Kouzmenko A, Nohara K, Chiba T et al (2007) Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature 446: 562–566
Wang X, Porter W, Krishnan V, Narasimhan TR, Safe S (1993) Mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated decrease of the nuclear estrogen receptor in MCF-7 human breast cancer cells. Mol Cell Endocrinol 96: 159–166
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Birkhäuser Verlag/Switzerland
About this chapter
Cite this chapter
Rüegg, J., Penttinen-Damdimopoulou, P., Mäkelä, S., Pongratz, I., Gustafsson, JÅ. (2009). Receptors mediating toxicity and their involvement in endocrine disruption. In: Luch, A. (eds) Molecular, Clinical and Environmental Toxicology. Experientia Supplementum, vol 99. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-8336-7_11
Download citation
DOI: https://doi.org/10.1007/978-3-7643-8336-7_11
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-8335-0
Online ISBN: 978-3-7643-8336-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)